loading

Benitec Biopharma Inc Azioni (BNTC) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
36.46%
13.38
9.803 9.834 10.19 8.61
Operating Income/Loss
36.46%
-13.38
-9.803 -9.834 -10.19 -8.61
Nonoperating Income/Loss
83.77%
1.54
0.838 1.029 0.834 1.253
Income/Loss From Continuing Operations Before Tax
32.04%
-11.84
-8.965 -8.805 -9.354 -7.357
Income/Loss From Continuing Operations After Tax
32.04%
-11.84
-8.965 -8.805 -9.354 -7.357
Net Income/Loss
32.04%
-11.84
-8.965 -8.805 -9.354 -7.357
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
10.72%
45.97
41.52 41.16 38.60 22.08
Diluted Average Shares
10.72%
45.97
41.52 41.16 38.60 22.08
Basic Earnings Per Share
18.18%
-0.26
-0.22 -0.21 -0.24 -0.33
Diluted Earnings Per Share
18.18%
-0.26
-0.22 -0.21 -0.24 -0.33
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):